Breaking News
Get 40% Off 0
🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought it Read More
Close

Kissei Pharmaceutical Co Ltd (4547)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3,165.0 0.0    0.00%
02:00:29 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3240600001 
  • Volume: 32,200.000000000004
  • Bid/Ask: 3,160.0 / 3,170.0
  • Day's Range: 3,140.0 - 3,175.0
Kissei Pharmaceutical 3,165.0 0.0 0.00%

4547 Balance Sheet

 
Featured here, the Balance Sheet for Kissei Pharmaceutical Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets - 102249 105869 103379
Cash and Short Term Investments - 43205 47536 47709
Cash - - - -
Cash & Equivalents - 19907 24234 24140
Short Term Investments - 23298 23302 23569
Total Receivables, Net 28679 29501 27064 24651
Accounts Receivables - Trade, Net 28679 29501 27064 24651
Total Inventory - 24467 24581 24060
Prepaid Expenses - - - -
Other Current Assets, Total 3643 5076 6688 6959
Total Assets - 228453 231879 225410
Property/Plant/Equipment, Total - Net 24860 24596 24276 24386
Property/Plant/Equipment, Total - Gross 69786 69397 68739 68872
Accumulated Depreciation, Total -44926 -44801 -44465 -44486
Goodwill, Net - - - -
Intangibles, Net 1683 1935 1582 1480
Long Term Investments 106361 99200 99709 95707
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 22552 2 1 2
Other Assets, Total 24912 23811 27949 30393
Total Current Liabilities - 17229 16763 16500
Accounts Payable - 4838 4705 5070
Payable/Accrued - - - -
Accrued Expenses 1999 803 1833 838
Notes Payable/Short Term Debt - 1390 1390 1440
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 9431 10198 8835 9152
Total Liabilities - 30863 30251 28345
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax - 12659 12527 10871
Minority Interest - 1041 995 976
Other Liabilities, Total - -2846 -1424 -2882
Total Equity - 197590 201628 197065
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - 24356 24356 24356
Additional Paid-In Capital - 24226 24226 24226
Retained Earnings (Accumulated Deficit) - 124486 123705 121292
Treasury Stock - Common - -12405 -8158 -7765
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - 36927 37499 34956
Total Liabilities & Shareholders' Equity - 228453 231879 225410
Total Common Shares Outstanding 44.21 44.45 45.8 45.92
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4547 Comments

Write your thoughts about Kissei Pharmaceutical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email